<DOC>
	<DOCNO>NCT02177461</DOCNO>
	<brief_summary>Study assess efficacy tolerability Telmisartan 40-80 mg daily compare enalapril 10-20 mg daily elderly patient arterial hypertension .</brief_summary>
	<brief_title>Telmisartan Compared With Enalapril Elderly Patients With Blood Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Enalaprilat</mesh_term>
	<mesh_term>Telmisartan</mesh_term>
	<mesh_term>Clonidine</mesh_term>
	<criteria>Age ≥ 65 year Sitting systolic blood pressure ( SBP ) ≥ 160 mmHg diastolic blood pressure ( DBP ) ( safety maximum sit DBP 110 mmHg ) , measure manual cuff sphygmomanometer end washout period Written inform consent Secondary hypertension Malignant hypertension ( retinal haemorrhage , exudate papillary oedema ) Clinically significant sodium depletion define serum sodium level &lt; 130 mEq/L , clinically significant hyperkaliemia define serum potassium level &gt; 5.5 mEq/L , clinically significant hypokaliemia define serum potassium level &lt; 3.0 mEq/L Atrial fibrillation frequent ventricular ectopic beat arrhythmia could interfere cardiac rhythm Heart rate &lt; 50 bpm Congestive heart failure ( CHF ) ( NYHA ( New York Heart Association ) functional class CHF IIIIV ) Angina pectoris myocardial infarction Cardiac surgery within past 3 month prior start washout period Stroke within past 6 month prior start washout period Renal insufficiency define creatininaemia &gt; 2mg/dl Bilateral renal artery stenosis , renal artery stenosis solitary kidney , post renal transplant Liver insufficiency , define bilirubinaemia &gt; 2mg/dl AST ( aspartate aminotransferase ) ALT ( alanineaminotransferase ) &gt; twice upper normal range Clinically significant metabolic endocrine disease Autoimmune disease Previous history angioedema Body mass index &gt; 30kg/m2 Arm circumference &gt; 32 cm Any condition may likely compromise trial ( alcohol drug abuse , disability illness , etc . ) Concomitant therapy antihypertensive drug nonpermitted protocol , present use tricyclic antidepressant , corticosteroid drug know affect blood pressure Investigational drug treatment within past 30 day enrolment concurrent participation trial Sensitivity , significant adverse reaction contraindication study drug ( telmisartan , enalapril , clonidine TTS ) Predictable lack patient cooperation</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>